Efficient Liposome Loading onto Surface of Mesenchymal Stem Cells via Electrostatic Interactions for Tumor-Targeted Drug Delivery

被引:5
|
作者
Kono, Yusuke [1 ]
Kamino, Renpei [1 ]
Hirabayashi, Soma [1 ]
Kishimoto, Takuya [1 ]
Kanbara, Himi [1 ]
Danjo, Saki [1 ]
Hosokawa, Mika [1 ]
Ogawara, Ken-ichi [1 ]
机构
[1] Kobe Pharmaceut Univ, Lab Pharmaceut, 4-19-1 Motoyamakita Machi,Higashinada Ku, Kobe 6588558, Japan
关键词
mesenchymal stem cell; drug delivery; tumor targeting; electrostatic interaction; magnetic liposome; IRON-OXIDE NANOPARTICLES; DIFFERENTIATION; PERMEABILITY; DOXORUBICIN; PARTICLES; THERAPY;
D O I
10.3390/biomedicines11020558
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mesenchymal stem cells (MSCs) have a tumor-homing capacity; therefore, MSCs are a promising drug delivery carrier for cancer therapy. To maintain the viability and activity of MSCs, anti-cancer drugs are preferably loaded on the surface of MSCs, rather than directly introduced into MSCs. In this study, we attempted to load liposomes on the surface of MSCs by using the magnetic anionic liposome/atelocollagen complexes that we previously developed and assessed the characters of liposome-loaded MSCs as drug carriers. We observed that large-sized magnetic anionic liposome/atelocollagen complexes were abundantly associated with MSCs via electrostatic interactions under a magnetic field, and its cellular internalization was lower than that of the small-sized complexes. Moreover, the complexes with higher atelocollagen concentrations showed lower cellular internalization than the complexes with lower atelocollagen concentrations. Based on these results, we succeeded in the efficient loading of liposomes on the surface of MSCs by using large-sized magnetic anionic liposomes complexed with a high concentration of atelocollagen. The constructed liposome-loaded MSCs showed a comparable proliferation rate and differentiation potential to non-loaded MSCs. Furthermore, the liposome-loaded MSCs efficiently adhered to vascular endothelial cells and migrated toward the conditioned medium from cancer cells in vitro and solid tumor tissue in vivo. These findings suggest that liposome-loaded MSCs could serve as an efficient cell-based drug carrier for tumor-targeted delivery.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Mesenchymal Stem Cells Mediated Drug Delivery in Tumor-Targeted Therapy
    Xie, Mengying
    Tao, Lei
    Zhang, Ziqi
    Wang, Wei
    CURRENT DRUG DELIVERY, 2021, 18 (07) : 864 - 879
  • [2] Mesenchymal stem cells: A living carrier for active tumor-targeted delivery
    Zhang, Tianyuan
    Lin, Ruyi
    Wu, Honghui
    Jiang, Xinchi
    Gao, Jianqing
    ADVANCED DRUG DELIVERY REVIEWS, 2022, 185
  • [3] Liposome Formulation for Tumor-Targeted Drug Delivery Using Radiation Therapy
    Stolarz, Amanda J.
    Chhetri, Bijay P.
    Borrelli, Michael J.
    Jenkins, Samir, V
    Jamshidi-Parsian, Azemat
    Phillips, Joshua H.
    Fologea, Daniel
    Gandy, Jay
    Griffin, Robert J.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [4] Microemulsions and Nanostructures for Efficient Tumor-Targeted Drug Delivery
    Peralta-Rodriguez, Rene D.
    Mendoza-Mendoza, Esmeralda
    Liakos, Ioannis
    Grumezescu, Alexandru Mihai
    FRONTIERS IN NANOTECHNOLOGY, 2022, 4
  • [5] ScreenFect A: an efficient and low toxic liposome for gene delivery to mesenchymal stem cells
    Li, Li-Ming
    Ruan, Gui-Xin
    HuangFu, Ming-Yi
    Chen, Zhi-Lan
    Liu, Hui-Na
    Li, Lin-Xian
    Hu, Yu-Lan
    Han, Min
    Davidson, Gary
    Levkin, Pavel A.
    Gao, Jian-Qing
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 488 (1-2) : 1 - 11
  • [6] Inducing Controlled Release and Increased Tumor-Targeted Delivery of Chlorambucil via Albumin/Liposome Hybrid Nanoparticles
    Zhang, Quan
    Zhang, Li
    Li, Zemin
    Xie, Xingliang
    Gao, Xiurong
    Xu, Xiaohong
    AAPS PHARMSCITECH, 2017, 18 (08): : 2977 - 2986
  • [7] Employing mesenchymal stem cells to support tumor-targeted delivery of extracellular vesicle (EV)-encapsulated microRNA-379
    K. P. O’Brien
    S. Khan
    K. E. Gilligan
    H. Zafar
    P. Lalor
    C. Glynn
    C. O’Flatharta
    H. Ingoldsby
    P. Dockery
    A. De Bhulbh
    J. R. Schweber
    K. St John
    M. Leahy
    J. M. Murphy
    W. M. Gallagher
    T. O’Brien
    M. J. Kerin
    R. M. Dwyer
    Oncogene, 2018, 37 : 2137 - 2149
  • [8] Inducing Controlled Release and Increased Tumor-Targeted Delivery of Chlorambucil via Albumin/Liposome Hybrid Nanoparticles
    Quan Zhang
    Li Zhang
    Zemin Li
    Xingliang Xie
    Xiurong Gao
    Xiaohong Xu
    AAPS PharmSciTech, 2017, 18 : 2977 - 2986
  • [9] Employing mesenchymal stem cells to support tumor-targeted delivery of extracellular vesicle (EV)-encapsulated microRNA-379
    O'Brien, K. P.
    Khan, S.
    Gilligan, K. E.
    Zafar, H.
    Lalor, P.
    Glynn, C.
    O'Flatharta, C.
    Ingoldsby, H.
    Dockery, P.
    De Bhulbh, A.
    Schweber, J. R.
    St John, K.
    Leahy, M.
    Murphy, J. M.
    Gallagher, W. M.
    O'Brien, T.
    Kerin, M. J.
    Dwyer, R. M.
    ONCOGENE, 2018, 37 (16) : 2137 - 2149
  • [10] Engineering Mesenchymal Stem Cells (MSCs) to support tumor-targeted delivery of exosome-encapsulated microRNA-379
    O'Brien, Killian P.
    Gilligan, Katie
    Khan, Sonja
    Moloney, Brian
    Thompson, Kerry
    Lalor, Pierce
    Dockery, Peter
    Ingoldsby, Helen
    Kerin, Michael J.
    Dwyer, Roisin M.
    CANCER RESEARCH, 2017, 77